destiny-breast07: t-dxd /- pertuzumab in patients with metastatic her2 breast cancer
Published 1 year ago • 115 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
1:08
updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
-
0:48
evaluating the safety of t-dxd with radiotherapy in her2 metastatic breast cancer
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
1:32
destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
4:29
pertuzumab, trastuzumab and cyclophosphamide in older patients with her2 breast cancer
-
4:55
pertuzumab in her2 breast cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
3:36
trastuzumab deruxtecan in patients with breast cancer and brain metastases in destiny-breast01
-
7:12
t-dxd demonstrates high levels of efficacy in patients with her2 unresectable and/or mbc previo...
-
2:02
dr tarantino on updated survival data with t-dxd in her2 breast cancer
-
5:55
decision-making in metastatic her2 breast cancer
-
4:15
debbrah: t-dxd in her2 or her2-low advanced breast cancer with cns involvement
-
0:58
comparing and sequencing t-dm1 and t-dxd in her2 breast cancer
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
2:15
treatment strategies for her2 metastatic breast cancer
-
11:32
final results from destiny-crc01: t-dxd in her2-expressing mcrc